metastasis at the time of operation. The high MVD group ( 6 26.0, n = 50) tended to have a poorer prognosis than the low MVD group ( ! 26.0, n = 42) (p = 0.097). Next, the 50 patients in the high MVD group were classifi ed into two subgroups of high MPI ( 6 78.1%, n = 25) and low MPI ( ! 78.1%, n = 25). MPI showed a signifi cant negative correlation with hematogenous metastasis, and the low MPI group demonstrated a signifi cantly poorer survival than the high MPI group (p = 0.040). Conclusions: These fi ndings demonstrate that immature neovascularization was observed in poorly differentiated tumors and was correlated with metastasis, resulting in a poorer prognosis. Taken together, not only microvessel density but also vascular maturation were crucial factors for colorectal cancer patients.
and metastasis [3] . Tumors secrete various growth factors that act on endothelial cells to recruit blood vessels from the neighboring tissues by angiogenesis. Tumor angiogenesis generally begins by destabilizing the vessels. Endothelial cells and mesenchymal cells stimulated by hypoxia as well as tumor cells themselves [4, 5] secrete angiopoietin-2 (Ang-2), resulting in the pericytes dissociating from pre-existing vessels. As a result, the endothelial cells can migrate, proliferate and assemble into tubes from preexisting vessels in the presence of primarily vascular endothelial growth factor (VEGF) produced by tumor cells and stromal cells. VEGF can initiate vessel formation, but by itself promotes the formation of only leaky, immature and unstable vessels [6] . When the concentration of Ang-2 is lower than that of angiopoietin-1 (Ang-1) in the microenvironment, Ang-1 recruits pericytes to these immature vessels, stabilizes the vessel walls and subsequently causes the new vessels to mature. Many studies reported that the intratumoral microvessel density (MVD) was correlated with the prognosis or distant metastasis of patients with various cancers, including breast [7] , prostate [8] , stomach [9] and colon [10] . Immature microvessels, which are not covered by pericytes, are irregular, tortuous and leaky. Therefore, we hypothesized that tumor cells could intravasate into immature microvessels more easily than into mature microvessels, and that the maturation as well as the density of the microvessels would contribute to the malignant potential of the tumor. There have been few clinical studies on the relationship between the maturity of the tumor microvessels and clinicopathological variables [11] [12] [13] . Furthermore, there have been no clinical studies on the relationship between the distant metastasis or prognosis of patients and the maturity of the tumor microvessels evaluated by the identifi cation of endothelial cells and pericytes. In this study, we investigated the maturation of angiogenesis and its relationship to the microvessel count, clinicopathological variables, distant metastasis and prognosis, using surgical specimens of colorectal cancers.
Materials and Methods

Tissue Samples
Surgical specimens were obtained from 92 patients with colorectal cancer who underwent colorectomies in the First Department of Surgery at Kyoto University Hospital from May 1995 to December 1996. The patients with additional cancers were excluded. Patient age ranged from 39 to 87 years (mean 8 SD, 65.3 8 11.9 years). There were 56 men and 36 women. The mean follow-up period for the patients without cancer death was 65.2 8 23.8 months after surgical resection. The histopathological diagnosis was confi rmed by the clinicopathological department of the hospital. Written informed consent was obtained from all patients for surgery and for the use of their resected samples. Hematoxylin and eosin staining was performed routinely to determine the histologic tumor type, lymphatic invasion and vascular invasion in all specimens.
Immunohistochemical Staining
For immunohistochemical analysis, 4-m-thick formalin-fi xed and paraffi n-embedded sections were prepared. To quantitatively assess the pericyte coverage of the microvessels, a Histostain-DS kit (Zymed, South San Francisco, Calif., USA) was used to simultaneously stain the endothelial cells and pericytes according to the manufacturer's protocol [11] . Briefl y, the sections were deparaffi nized in xylene and rehydrated. For antigen retrieval, the sections were immersed in 0.05 M Tris-HCl buffer (pH 7.2) at 37 ° C for 30 min and incubated with 0.1% trypsin at 37 ° C for 30 min. After quenching the endogenous peroxidase activity with 0.3% hydrogen peroxide and incubating with goat serum to block nonspecifi c binding, the sections were then incubated with a monoclonal mouse antihuman ␣ -smooth muscle actin (SMA) antibody (clone 1A4, 1: 50 dilution; DakoCytomation, Kyoto, Japan) for 1 h at room temperature. A biotinylated secondary antibody, streptavidin alkaline phosphate complex, and nitroblue tetrazolium as a substrate were used to visualize the binding of the ␣ -SMA antibody. The sections were then incubated with double staining enhancer for 30 min at room temperature. Subsequent immunostaining of the endothelial cells was performed by the same method described above, except for the use of a mouse antihuman CD34 antibody (QBEnd/10, diluted; NeoMarkers, Fremont, Calif., USA) as the primary antibody, streptavidin peroxidase as the enzyme and 3-amino-9-ethyl carbazole as the substrate. The double immunostained sections were mounted with an aqueous mounting medium, and Histomount (Zymed) was dropped over the hardened aqueous mounting medium to improve resolution under the microscope and the sections were coverslipped.
Evaluation of Immunostaining and Vessel Counting
The evaluation of the MVD and microvessel pericyte coverage index (MPI) was performed without knowledge of the patients' clinicopathological features. The MVD was assessed with a light microscope, and microvessels were defi ned as any lumen that was separate from any adjacent vessels [14, 15] . To determine the high vascular spots within the tumor, we fi rst identifi ed the tumor area by scanning the hematoxylin and eosin-stained section. Then, we determined the fi ve highest vascular spots in the corresponding tumor area on the double immunohistochemical-stained serial section at a low magnifi cation ( ! 40). Digital photographs of each spot were taken at ! 400 magnifi cation (corresponding to a 0.237-mm 2 area) to obtain accurate microvessel counts, and the average counts from the fi ve spots were recorded. Pericytes were defi ned as a single layer of ␣ -SMA-positive cells colocalized with CD34-positive microvessels. The MPI was determined by calculating the number of microvessels associated with ␣ -SMA-positive pericytes/the total number of microvessels on the same fi ve areas where we assessed the MVD. The average percentages from the fi ve areas were then recorded [11] .
Statistical Analysis
Survival was calculated from the date of the colorectomy to the date of death or of the last follow-up. The clinical and histopathological characteristics of the patients in relation to their MVD or MPI were compared, and the statistical signifi cance was assessed with the Mann-Whitney U test or the Spearman rank correlation coeffi cient. An overall survival curve was plotted according to the Kaplan-Meier method, and the statistical differences were analyzed by the log rank test. Correlations between the MVD and MPI were examined by the Spearman rank correlation coeffi cient. All statistical analyses were performed with Stat View for Windows Version 4.54 (AbacusConcepts, Berkeley, Calif., USA). For all statistical analysis, p ! 0.05 was considered to be statistically signifi cant.
Results
MVD and MPI in Colorectal Cancers
The high vascular spots for CD34 immunostaining within the tumor were frequently found at the peritumoral sites. The MVD in tumors immunostained for CD34 varied between 10.6 per high power fi eld (HPF) and 44.4/HPF (mean 8 SD, 27.6 8 7.9/HPF; median 26.8/HPF). The MPI in the tumors determined by quantifying the percentage of microvessels that colocalized endothelial immunostaining (CD34; red) and pericyte immunostaining ( ␣ -SMA; dark blue) varied between 27.9 and 97.8% (mean 8 SD, 69.7 8 16.8%; median 72.8%). Representative high MPI sections and low MPI sections are shown in fi gure 1 . We examined the relationship between the MVD and MPI. On analysis by the Spearman 
Correlation between the MVD or MPI with the Patient Profi le, Clinicopathological Variables and Patient Prognosis
The association of the MVD with the clinicopathological variables is shown in table 1 . The MVD was signifi cantly correlated with the tumor size, depth of invasion and Dukes' stage. The association of the MPI with the clinicopathological variables is shown in table 2 . The MPI was signifi cantly positively correlated with the histological type; in other words, the level of immaturity of the tumor microvessels was signifi cantly correlated with the level of immaturity of tumor differentiation. In addition, the MPI was signifi cantly but inversely correlated with distant metastasis at the time of operation, including synchronous hematogenous metastasis, peritoneal dissemination and lymph node metastasis beyond the regional lymph nodes. When the 92 patients were classifi ed into two groups with a high MVD ( 6 26.0, n = 50) or a low MVD ( ! 26.0, n = 42), the high MVD group tended to have a poorer prognosis than the low MVD group (p = 0.097) ( fi g. 3 ).
Correlation of the MPI with the Patient Profi le, Clinicopathological Variables and Prognosis in the High MVD Group
The 50 patients in the high MVD group were classifi ed into two subgroups of high MPI ( 6 78.1%, n = 25) and low MPI ( ! 78.1%, n = 25) on the basis of the median MPI. The low MPI group, the group with a large fraction of immature tumor microvessels, demonstrated a signifi cantly poorer rate of survival than the high MPI group (p = ( table 3 ) . On the other hand, when the 42 patients from the low MVD group were classifi ed into the two subgroups of high MPI ( 6 67.7%, n = 21) and low MPI ( ! 67.7%, n = 21) on the basis of their median MPI, there were no signifi cant differences between the survival rate of the high MPI group versus that of the low MPI group (p = 0.47) ( fi g. 4 B).
Discussion
In the present study, we evaluated the maturation status as well as the magnitude of tumor angiogenesis in each colorectal cancer. The MPI is defi ned as the percentage of microvessels colocalized with ␣ -SMA-positive pericytes. We also examined the relationship between the MVD and MPI and found a signifi cantly positive correlation (r = 0.36, p = 0.0004). In other words, this observation indicated that tumor vessels in the high MVD tumors consisted of a higher percentage of mature tumor vessels than those in the low MVD tumors. On the other hand, Vermeulen et al. [16] demonstrated that in liver metastases from colorectal cancers, the fraction of immature microvessels correlated strongly with the MVD. Kakolyris et al. [17, 18] also reported a signifi cant association between a high vascular maturation index and a low microvessel score in non-small-cell lung carcinomas. The reason for these confl icting results remains unclear, but this discrepancy might be partially due to the differences in tumor type and primary or metastatic tumors.
Our results revealed that the MPI correlated significantly with the histological type. This indicated that the maturity of the tumor microvessels was signifi cantly correlated with the degree of tumor differentiation. This observation is consistent with previous reports on renal cell carcinomas [12] and astrocytomas [13] . In addition, the MPI correlated signifi cantly with distant metastasis at the time of operation, which might suggest that the immature vessels were leaky, so the cancer cells in the low MPI tumors could penetrate into the microvessels more easily, and subsequently led to the formation of distant metastasis. On the other hand, immature tumor microvessels are unstable because of continual remodeling, that is, growth and regression. The destabilization might also contribute to metastatic cell intravasation. This is another kinetic event we cannot explain only by the present double immunohistochemical study. Further basic studies on the mechanisms of our results are needed.
With regard to the MVD, our results showed that it was signifi cantly correlated with the tumor size, depth of invasion and Dukes' stage, which is consistent with previous studies [10, 19, 20] . In this study, the univariate analysis using the Kaplan-Meier method revealed that the high MVD group tended to have a poorer prognosis than the low MVD group. We further classifi ed the 50 patients in the high MVD group into two subgroups of high MPI and low MPI. The low MPI subgroup, which had a large fraction of immature tumor microvessels, was found to have a signifi cantly poorer rate of survival as compared with the high MPI group. Moreover, the MPI showed a signifi cant correlation with distant metastasis at the time of operation, Dukes' stage and hematogenous metastasis. These observations suggested that in colorectal cancers, as the number of tumor microvessels increased, the percentage of mature microvessels ordinarily became higher. However, when there were a large number of microvessels without concomitant maturation, the tumor obtained a higher malignant potential.
Many clinical studies, including ours, have reported that colorectal cancer cells themselves secrete VEGF [15, [20] [21] [22] and Ang-2 [23] . The immaturity of the tumor microvessels might be determined by a balance between the various angiogenic factors secreted by the tumors and host tissues [4, 14, 24] . Our recent study reported that VEGF reduced mural cell coverage of endothelial cells by transmission electron microscopic observations in an in vivo tumor angiogenesis model [25] . The differences in the degree of immaturity of tumor vessels among colorectal cancers should be studied in future investigations, including the distribution and combination of VEGF, Ang-1, Ang-2, placenta growth factor and other pro-and antiangiogenic factors.
In this study, we used double immunohistochemical staining with antibodies against CD34 for vascular endothelial cells and against ␣ -SMA for pericytes. CD34 is expressed on vascular endothelial cells, and the anti-CD31 antibody, unlike the anti-CD34 antibody, immunostains vascular endothelial cell as well as lymph endothelial cell [26] [27] [28] . Since lymph vessels have no pericytes, we could not distinguish immature vascular vessels from lymph vessels when using the anti-CD31 antibody. Tomisaki et al. [29] reported that nonspecifi c CD34 immunostaining of leucocytes and other infl ammatory cells can also occur. Therefore, in this study, we defi ned a microvessel as a lumen showing positive immunostaining for CD34 to avoid false positives.
Pericytes cover capillaries and postcapillary venules and play a crucial role in infl uencing endothelial permeability and maturation [30] . However, there is no pericyte marker that identifi es all pericytes, and they are now commonly identifi ed by molecular markers such as ␣ -SMA, desmin or high-molecular weight melanoma-associated antigen [31] [32] [33] . Among normal capillaries, ␣ -SMA is expressed in precapillaries and postcapillaries, but not midcapillaries, whereas normal venular pericytes express ␣ -SMA [34] . Kurz et al. [35] reported that pericytes expressed desmin, but not ␣ -SMA, at the early stages of capillary sprouting in avian chorioallantoic membrane tumor angiogenesis assays. On the other hand, Morikawa et al. [36] reported that pericytes in large tumors uniformly expressed both ␣ -SMA and desmin even on capillary-size vessels in three experimental mouse tumor models. In our study, we used established human large tumors. In fact, the size of the tumors we examined ranged from 1.2 to 11.2 cm (mean 8 SD, 4.6 8 2.1 cm). In addition, our preliminary study showed that almost all ␣ -SMA-positive microvessels also expressed desmin, whereas almost all ␣ -SMA-negative microvessels did not express desmin (data not shown). These fi ndings are consistent with previous reports [37, 38] . To date, very little is known about the appropriate pericyte markers in tumor angiogenesis of human established tumors. Further examinations are needed.
In this study, we used 4-m sections. On the other hand, Morikawa et al. [36] used 100-m-thick sections in confocal microscopic studies looking at pericyte morphologies and pericyte coverage of vessels. A 4-m section may not be indicative of pericyte coverage morphology. However, we examined whether microvessels were colocalized with ␣ -SMA-positive pericytes or not and observed cross sections of as many as 138 vessels on average (53-222 vessels) in each tumor, although we did not observe the pericyte three-dimensional morphology itself. Thus, MPI could refl ect the microvessel maturity in a tumor.
Benjamin et al. [39] recently demonstrated that androgen ablation therapy for human prostate tumors leads to a downregulation of VEGF within the tumor, leading selectively to the regression of immature tumor microvessels that were not covered by ␣ -SMA-positive pericytes.
This report suggests that the low MPI group in colorectal carcinomas may regress after inducing the apoptosis of the immature vessels by specifi c antiangiogenic therapies such as anti-VEGF treatment. In other words, although those cases with many immature vessels have a poor prognosis, they might have a good response to antiangiogenic therapy, such as VEGF withdrawal.
In conclusion, these fi ndings demonstrated that neovascularization without concomitant vascular maturation correlated with poorly differentiated tumors, distant metastasis and a poor prognosis for colorectal cancer patients. Taken together, the evaluation of tumor angiogenesis from the viewpoint of its maturation as well as its quantity is useful for predicting the malignant potential of the tumor and will be applied to molecular-targeting antiangiogenic therapy in the near future.
